Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Latifi, Ardian ^a,b   Luwor, Rodney B ^b   Bilandzic, Maree ^c   Nazaretian, Simon ^a   Stenvers, Kaye ^c   Pyman, Jan ^a   Zhu, Hongjian ^b   Thompson, Erik W ^b,d   Quinn, Michael A ^a,b   Findlay, Jock K ^a,b,c   Ahmed, Nuzhat ^a,b,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d St Vincent Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN 7; DOCETAXEL; DOXORUBICIN; EPITHELIAL CELL ADHESION MOLECULE; GEMCITABINE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; STAT3 PROTEIN; TOPOTECAN; UVOMORULIN;

ADULT; ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES TUMOR CELL; CANCER INFILTRATION; CANCER PATIENT; CANCER STAGING; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL POPULATION; CELL SPREADING; CELL STRUCTURE; CELL SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE PRODUCT; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATION AND PURIFICATION; MESENCHYMAL STEM CELL; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OVARY CARCINOMA; PHENOTYPE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ASCITES; CELL ADHESION; CELL SEPARATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PHENOTYPE; RNA, MESSENGER; SPHEROIDS, CELLULAR; SURVIVAL ANALYSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84867320871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046858     Document Type: Article

References (51)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Kuhn E, Kurman RJ, Shih IM, (2012) Ovarian Cancer Is an Imported Disease: Fact or Fiction? Curr Obstet Gynecol Rep 1: 1-9.
3. Lengyel E, (2010) Ovarian cancer development and metastasis. Am J Pathol 177: 1053-1064.
4. Ozols RF, (2006) Systemic therapy for ovarian cancer: current status and new treatments. Semin Oncol 33: S3-11.
5. Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, et al. (2009) Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 69: 2400-2407.
6. Ahmed N, Abubaker K, Findlay J, Quinn M, (2010) Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10: 268-278.
7. Ahmed N, Thompson EW, Quinn MA, (2007) Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 213: 581-588.
8. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou, et al, (2008) The epithelial- mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
9. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A, (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3: e28888.
10. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, et al. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 106: 13820-13825.
11. Haviv I, Thompson EW, (2012) Soiling the seed: microenvironment and epithelial mesenchymal plasticity. Cancer Microenviron 5: 1-3.
12. Gao D, Joshi N, Choi H, Ryu S, Hahn M, et al. (2012) Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res 72: 1384-1394.
13. Celia-Terrassa T, Meca-Cortes O, Mateo F, de Paz AM, Rubio N, et al. (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849-1868.
14. Brabletz T (2012) To differentiate or not- routes towards metastasis. Nat Rev Cancer.
15. Davidson B, (2001) Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature. Anal Cell Pathol 23: 107-128.
16. Kenny HA, Dogan S, Zillhardt M, A KM, Yamada SD, et al. (2009) Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis. Cancer Treat Res 149: 335-351.
17. Bapat SA, Mali AM, Koppikar CB, Kurrey NK, (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65: 3025-3029.
18. Alison MR, Lim SM, Nicholson LJ, (2010) Cancer stem cells: problems for therapy? J Pathol 223: 147-161.
19. Liu HG, Chen C, Yang H, Pan YF, Zhang XH, (2011) Cancer stem cell subsets and their relationships. J Transl Med 9: 50.
20. Kunimura C, Kikuchi K, Ahmed N, Shimizu A, Yasumoto S, (1998) Telomerase activity in a specific cell subset co-expressing integrinbeta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells. Oncogene 17: 187-197.
21. Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, et al. (2011) Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J Cell Biochem 112: 2850-2864.
22. Bilandzic M CS, Farnworth PG, Harrison C, Nicholls P, Wang Y, Escalona RM, Fuller PJ, Findlay JK, Stenvers KL, (2009) Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells. Mol Endocrinol 23: 539-548.
23. Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, et al. (2010) Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med 15: 635-646.
24. Ho C, Chang SW, Hsiao CC, Chien TY, Shih DTB, (2012) Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma. J Biomed Sci 14: 19-23.
25. Antolovic D, Galindo L, Carstens A, Rahbari N, Buchler MW, et al. (2010) Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies. BMC Biotechnol 10: 35.
26. Scarberry KE, Dickerson EB, Zhang ZJ, Benigno BB, McDonald JF, (2010) Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles. Nanomedicine 6: 399-408.
27. Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, et al. (2009) Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Int J Gynecol Cancer 19: 860-866.
28. Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, et al. (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2 5(12): e232.
29. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, et al. (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992.
30. Udagawa T, Puder M, Wood M, Schaefer BC, D'Amato RJ, (2006) Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J 20: 95-102.
31. Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, et al. (2010) Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 124: 317-326.
32. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, et al. (2010) Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 5: e12180.
33. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
34. McLean K YG, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR, Buckanocich RJ, (2011) Human ovarian carcinoma-associated mesenchymal stem cells regulate csancer stem cells and tumorigenesis via altered BMP production. J Clinical Investigation 121: 3206-3219.
35. Radisky ES, Radisky DC, (2010) Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15: 201-212.
36. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, et al. (2009) Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8: 158-166.
37. Zhang S, Balch C, Chan MW, Lai HC, Matei D, et al. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320.
38. Peng S, Maihle NJ, Huang Y, (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29: 2153-2159.
39. Lin L, Liu A, Peng Z, Lin HJ, Li PK, et al. (2011) STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res 71: 7226-7237.
40. Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, et al. (2012) Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One 7: e29079.
41. Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, et al. (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363: 943-953.
42. Bartkowiak K, Riethdorf S, Pantel K, (2012) The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis. Cancer Microenviron 5: 59-72.
43. Bose D, Zimmerman LJ, Pierobon M, Petricoin E, Tozzi F, et al. (2011) Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Br J Cancer 105: 1759-1767.
44. Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, et al. (2006) Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 103: 483-488.
45. Kleinberg L, Pradhan M, Trope CG, Nesland JM, Davidson B, et al. (2008) Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors. Diagn Cytopathol 36: 637-644.
46. Schauer IG, Sood AK, Mok S, Liu J, (2011) Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 13: 393-405.
47. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, et al. (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8: 784-804.
48. Velasco-Velazquez MA, Homsi N, De La Fuente M, Pestell RG, (2012) Breast cancer stem cells. Int J Biochem Cell Biol 44: 573-577.
49. Gingis-Velitski S, Loven D, Benayoun L, Munster M, Bril R, et al. (2011) Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice. Cancer Res 71: 6986-6996.
50. Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM, (2012) Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 30: 292-303.
51. Kandala PK, Srivastava SK, (2012) Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). BMC Med 10: 9.